Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Nov-24 9:06 PM View:  | Hopkins Janet Jill Chief Medical Officer | Aura Biosciences, Inc. (AURA) | 18-Nov-24 | Sale | 11,822 | $9.36 | $110,663.00 | (7%) 163.51K to 151.69K | |
| 16-Oct-24 9:25 PM View: | Plavsic Mark Chief Technology Officer | Aura Biosciences, Inc. (AURA) | 16-Oct-24 | Sale | 7,383 | $9.85 | $72,722.60 | (6%) 128.51K to 121.13K | |
| 01-Oct-24 5:08 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 27-Sep-24 | Option Exercise | 5,474 | $5.76 | $31,530.20 | 1% 455.79K to 461.26K | |
| 24-Jun-24 4:09 PM View: | Mattessich Antony C. Director | Aura Biosciences, Inc. (AURA) | 20-Jun-24 | Grant | 10,500 | -- | -- | 100% 0 to 10.5K | |
| 24-Jun-24 4:08 PM View: | Srivastava Sapna Director | Aura Biosciences, Inc. (AURA) | 20-Jun-24 | Grant | 10,500 | -- | -- | 100% 0 to 10.5K | |
| 24-Jun-24 4:05 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 20-Jun-24 | Grant | 10,500 | -- | -- | 2% 425.34K to 435.84K | |
| 04-Apr-24 4:10 PM View: | Kilroy Conor General Counsel and Secretary | Aura Biosciences, Inc. (AURA) | 02-Apr-24 | Grant | 96,000 | -- | -- | 100% 0 to 96.0K | |
| 02-Feb-24 4:01 PM View: | Hopkins Janet Jill Chief Medical Officer | Aura Biosciences, Inc. (AURA) | 01-Feb-24 | Grant | 28,515 | -- | -- | 21% 135.0K to 163.51K | |
| 02-Feb-24 4:01 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 01-Feb-24 | Grant | 71,285 | -- | -- | 113% 62.99K to 134.28K | |
| 02-Feb-24 4:01 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 01-Feb-24 | Grant | 162,935 | -- | -- | 56% 292.85K to 455.79K | |
| 24-Jan-24 4:20 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 23-Jan-24 | Sale | 15,853 | $7.64 | $121,141.00 | (5%) 308.7K to 292.85K | |
| 24-Jan-24 4:18 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 23-Jan-24 | Sale | 6,609 | $7.64 | $50,521.20 | (9%) 69.6K to 62.99K | |
| 09-Nov-23 4:35 PM View: | Matrix Capital Management C... 10% Owner | Aura Biosciences, Inc. (AURA) | 09-Nov-23 | Private Purchase | 1,560,000 | $9.00 | $14,040,000.00 | 29% 5.36M to 6.92M | |
| 09-Nov-23 5:02 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 08-Nov-23 | Purchase | 9,601 | $7.30 | $70,087.30 | 2% 460.74K to 470.34K | |
| 09-Nov-23 5:02 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 08-Nov-23 | Purchase | 20,000 | $7.30 | $146,000.00 | 4% 470.34K to 490.34K | |
| 09-Nov-23 5:02 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 07-Nov-23 | Private Purchase | 76,000 | $7.17 | $544,920.00 | 26% 290.74K to 366.74K | |
| 09-Nov-23 5:02 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 07-Nov-23 | Purchase | 94,000 | $7.17 | $673,980.00 | 26% 366.74K to 460.74K | |
| 07-Nov-23 6:19 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 06-Nov-23 | Planned Option Sale | 3,800 | $12.03 | $45,713.60 | (1%) 316.15K to 312.35K | |
| 07-Nov-23 6:09 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 06-Nov-23 | Option Exercise | 3,900 | $2.74 | $10,686.00 | 6% 69.6K to 73.5K | |
| 07-Nov-23 6:19 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 06-Nov-23 | Option Exercise | 3,800 | $2.74 | $10,412.00 | 1% 312.35K to 316.15K | |
| 07-Nov-23 6:19 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 06-Nov-23 | Sale (Planned) | 3,649 | $12.03 | $43,897.10 | (1%) 312.35K to 308.7K | |
| 07-Nov-23 6:09 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 06-Nov-23 | Planned Option Sale | 3,900 | $12.07 | $47,053.90 | (5%) 73.5K to 69.6K | |
| 03-Nov-23 5:04 PM View: | Hopkins Janet Jill Chief Medical Officer | Aura Biosciences, Inc. (AURA) | 01-Nov-23 | Grant | 135,000 | -- | -- | 100% 0 to 135.0K | |
| 01-Nov-23 6:24 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 30-Oct-23 | Sale | 3,385 | $6.82 | $23,090.80 | (5%) 72.98K to 69.6K | |
| 01-Nov-23 6:21 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 30-Oct-23 | Sale | 9,586 | $6.83 | $65,478.10 | (3%) 321.94K to 312.35K | |
| 05-Oct-23 7:56 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 04-Oct-23 | Purchase | 6,566 | $8.61 | $56,512.20 | 3% 219.17K to 225.74K | |
| 05-Oct-23 7:56 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 03-Oct-23 | Private Purchase | 13,500 | $8.27 | $111,663.00 | 7% 205.67K to 219.17K | |
| 23-Jan-23 6:35 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 19-Jan-23 | Grant | 121,875 | -- | -- | 61% 200.06K to 321.94K | |
| 23-Jan-23 6:36 PM View: | de Rosch Mark Chief Operating Officer | Aura Biosciences, Inc. (AURA) | 19-Jan-23 | Grant | 42,250 | -- | -- | 258% 16.39K to 58.63K | |
| 23-Jan-23 6:34 PM View: | Rich Cadmus See Remarks | Aura Biosciences, Inc. (AURA) | 19-Jan-23 | Grant | 34,125 | -- | -- | 139% 24.58K to 58.7K | |
| 23-Jan-23 6:38 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 19-Jan-23 | Grant | 48,750 | -- | -- | 201% 24.23K to 72.98K | |
| 09-Jan-23 5:55 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 06-Jan-23 | Purchase | 1,604 | $10.51 | $16,851.00 | 5% 34.4K to 36.0K | |
| 09-Jan-23 5:55 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 05-Jan-23 | Private Purchase | 396 | $10.00 | $3,960.00 | 1% 34.0K to 34.4K | |
| 30-Dec-22 7:01 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 28-Dec-22 | Private Purchase | 4,000 | $9.75 | $39,000.00 | 13% 30.0K to 34.0K | |
| 07-Dec-22 4:30 PM View: | Matrix Capital Management C... 10% Owner | Aura Biosciences, Inc. (AURA) | 05-Dec-22 | Private Purchase | 1,250,000 | $12.00 | $15,000,000.00 | 30% 4.11M to 5.36M | |
| 15-Dec-22 6:15 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 01-Dec-22 | Private Purchase | 10,000 | $12.37 | $123,700.00 | 50% 20.0K to 30.0K | |
| 02-Nov-22 8:38 PM View: | Rich Cadmus See Remarks | Aura Biosciences, Inc. (AURA) | 31-Oct-22 | Sale (Planned) | 1,672 | $12.45 | $20,813.20 | (6%) 26.25K to 24.58K | |
| 02-Nov-22 8:39 PM View: | Feder Julie B Chief Financial Officer | Aura Biosciences, Inc. (AURA) | 31-Oct-22 | Sale (Planned) | 2,015 | $12.45 | $25,089.60 | (8%) 26.25K to 24.23K | |
| 02-Nov-22 8:37 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 31-Oct-22 | Sale (Planned) | 5,706 | $12.46 | $71,081.90 | (3%) 205.77K to 200.06K | |
| 02-Nov-22 8:36 PM View: | de Rosch Mark Chief Operating Officer | Aura Biosciences, Inc. (AURA) | 31-Oct-22 | Sale (Planned) | 1,115 | $12.46 | $13,890.00 | (6%) 17.5K to 16.39K | |
| 14-Jun-22 9:29 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 13-Jun-22 | Purchase | 20,000 | $13.99 | $279,800.00 | 67% 30.0K to 50.0K | |
| 14-Jun-22 9:29 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 13-Jun-22 | Purchase | 14,000 | $13.99 | $195,860.00 | 88% 16.0K to 30.0K | |
| 14-Jun-22 9:29 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 10-Jun-22 | Private Purchase | 6,000 | $15.04 | $90,240.00 | 100% 0 to 6.0K | |
| 14-Jun-22 9:29 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 10-Jun-22 | Purchase | 10,000 | $15.04 | $150,400.00 | 167% 6.0K to 16.0K | |
| 04-Nov-21 5:00 PM View: | Medicxi Ventures Management... 10% Owner | Aura Biosciences, Inc. (AURA) | 02-Nov-21 | Conversion | 2,329,890 | -- | -- | 100% 0 to 2.33M | |
| 04-Nov-21 4:44 PM View: | Matrix Capital Management C... 10% Owner | Aura Biosciences, Inc. (AURA) | 02-Nov-21 | Private Purchase | 1,785,000 | $14.00 | $24,990,000.00 | 38% 4.66M to 6.44M | |
| 02-Nov-21 4:13 PM View: | de Los Pinos Elisabet See Remarks Director | Aura Biosciences, Inc. (AURA) | 02-Nov-21 | Conversion | 4,552 | -- | -- | 2% 201.22K to 205.77K | |
| 04-Nov-21 5:00 PM View: | Medicxi Ventures Management... 10% Owner | Aura Biosciences, Inc. (AURA) | 02-Nov-21 | Private Purchase | 710,000 | $14.00 | $9,940,000.00 | 30% 2.33M to 3.04M | |
| 02-Nov-21 4:11 PM View: | Johnson David Michael Director | Aura Biosciences, Inc. (AURA) | 02-Nov-21 | Conversion | 139,672 | -- | -- | 100% 0 to 139.67K | |
| 04-Nov-21 4:44 PM View: | Matrix Capital Management C... 10% Owner | Aura Biosciences, Inc. (AURA) | 02-Nov-21 | Conversion | 2,327,870 | -- | -- | 100% 2.33M to 4.66M |
